Abousaud, M., Faroqui, N., Hsu, F., Lesser, G., Strowd, R., Ramkissoon, S., . . . DeTroye, A. (2020). DDRE-17. INITIAL CLINICAL EXPERIENCE USING OSIMERTINIB IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS WITH EGFR ALTERATIONS. Neuro Oncol.
Chicago Style CitationAbousaud, Marin, et al. "DDRE-17. INITIAL CLINICAL EXPERIENCE USING OSIMERTINIB IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS WITH EGFR ALTERATIONS." Neuro Oncol 2020.
Cita MLAAbousaud, Marin, et al. "DDRE-17. INITIAL CLINICAL EXPERIENCE USING OSIMERTINIB IN PATIENTS WITH RECURRENT MALIGNANT GLIOMAS WITH EGFR ALTERATIONS." Neuro Oncol 2020.
Atenció: Aquestes cites poden no estar 100% correctes.